{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:57:22Z","timestamp":1787903842777,"version":"build-2784847793"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research,India","doi-asserted-by":"crossref","award":["ISRM\/12(117)\/2020, ID No. 2020-4900"],"award-info":[{"award-number":["ISRM\/12(117)\/2020, ID No. 2020-4900"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01448-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:19:38Z","timestamp":1751386778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-1094","authenticated-orcid":false,"given":"Saumya","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Saba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyabhaba","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3535-9019","authenticated-orcid":false,"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1448_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gene.2018.09.042","volume":"683","author":"S Singh","year":"2019","unstructured":"Singh, S. et al. Genomic alterations driving psoriasis pathogenesis. Gene 683, 61\u201371 (2019).","journal-title":"Gene"},{"key":"1448_CR2","first-page":"32","volume":"3","author":"GK Kim","year":"2010","unstructured":"Kim, G. K. & Del Rosso, J. Q. Drug-provoked psoriasis: Is it drug induced or drug aggravated?. J. Clin. Aesthet. Dermatol. 3, 32\u201338 (2010).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"1448_CR3","doi-asserted-by":"publisher","first-page":"ITC49","DOI":"10.7326\/AITC201804030","volume":"168","author":"M Lebwohl","year":"2018","unstructured":"Lebwohl, M. Psoriasis. Ann. Intern. Med. 168, ITC49\u2013ITC64 (2018).","journal-title":"Ann. Intern. Med."},{"key":"1448_CR4","doi-asserted-by":"crossref","unstructured":"Choudhary, S. et al. Transcriptomic landscaping of core genes and pathways of mild and severe psoriasis vulgaris. Int. J. Mol. Med. (2020).","DOI":"10.3892\/ijmm.2020.4771"},{"key":"1448_CR5","unstructured":"NCDs | Psoriasis. WHO http:\/\/www.who.int\/ncds\/management\/psoriasis\/en\/."},{"key":"1448_CR6","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.12788\/j.sder.2018.009","volume":"37","author":"AW Armstrong","year":"2018","unstructured":"Armstrong, A. W., Gordon, K. B., Menter, M. A. & Wu, J. J. The evolving landscape of psoriasis treatment. Semin. Cutan. Med. Surg. 37, S39\u2013S43 (2018).","journal-title":"Semin. Cutan. Med. Surg."},{"key":"1448_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-018-0276-9","volume":"10","author":"A Passi","year":"2018","unstructured":"Passi, A., Rajput, N. K., Wild, D. J. & Bhardwaj, A. RepTB: A gene ontology based drug repurposing approach for tuberculosis. J. Cheminform. 10, 1\u201312 (2018).","journal-title":"J. Cheminform."},{"key":"1448_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaad.2009.02.015","volume":"61","author":"M Makredes","year":"2009","unstructured":"Makredes, M., Robinson, D., Bala, M. & Kimball, A. B. The burden of autoimmune disease: A comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J. Am. Acad. Dermatol. 61, 405\u2013410 (2009).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"Suppl 2","key":"1448_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1468-3083.2009.03565.x","volume":"24","author":"S Prey","year":"2010","unstructured":"Prey, S. et al. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature. J. Eur. Acad. Dermatol. Venereol. 24(Suppl 2), 31\u201335 (2010).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"1448_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","volume":"67","author":"JJ Wu","year":"2012","unstructured":"Wu, J. J., Nguyen, T. U., Poon, K.-Y.T. & Herrinton, L. J. The association of psoriasis with autoimmune diseases. J. Am. Acad. Dermatol. 67, 924\u2013930 (2012).","journal-title":"J. Am. Acad. Dermatol."},{"key":"1448_CR11","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.jid.2016.04.035","volume":"136","author":"WR Swindell","year":"2016","unstructured":"Swindell, W. R., Sarkar, M. K., Liang, Y., Xing, X. & Gudjonsson, J. E. Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature. J. Invest. Dermatol. 136, 1820\u20131830 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"1448_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8717369","volume":"2017","author":"Y Gao","year":"2017","unstructured":"Gao, Y., Yi, X. & Ding, Y. Combined transcriptomic analysis revealed AKR1B10 Played an important role in psoriasis through the dysregulated lipid pathway and overproliferation of keratinocyte. BioMed Res. Int. 2017, 1\u201310. https:\/\/doi.org\/10.1155\/2017\/8717369 (2017).","journal-title":"BioMed Res. Int."},{"key":"1448_CR13","first-page":"1529","volume":"19","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Systematic screening and identification of novel psoriasis-specific genes from the transcriptome of psoriasis-like keratinocytes. Mol. Med. Rep. 19, 1529\u20131542 (2019).","journal-title":"Mol. Med. Rep."},{"key":"1448_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s13205-023-03533-y","volume":"13","author":"S Choudhary","year":"2023","unstructured":"Choudhary, S. et al. Exploring the molecular underpinning of psoriasis and its associated comorbidities through network approach: Cross talks of genes and pathways. 3 Biotech 13, 130 (2023).","journal-title":"3 Biotech"},{"key":"1448_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.semarthrit.2016.05.012","volume":"46","author":"LC Coates","year":"2016","unstructured":"Coates, L. C., FitzGerald, O., Helliwell, P. S. & Paul, C. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?. Semin. Arthritis Rheum. 46, 291\u2013304 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"1448_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","volume":"65","author":"S-Y Chu","year":"2011","unstructured":"Chu, S.-Y. et al. Comorbidity profiles among patients with alopecia areata: The importance of onset age, a nationwide population-based study. J. Am. Acad. Dermatol. 65, 949\u2013956 (2011).","journal-title":"J. Am. Acad. Dermatol."},{"key":"1448_CR17","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/jid.2011.162","volume":"131","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson, J. F., Lindel\u00f6f, B., Zingone, F. & Ciacci, C. Psoriasis in a nationwide cohort study of patients with celiac disease. J. Invest. Dermatol. 131, 2010\u20132016 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"1448_CR18","first-page":"232","volume":"53","author":"S Bellissimo","year":"2001","unstructured":"Bellissimo, S., Iannone, F., Musio, A., Covelli, M. & Lapadula, G. Association of systemic sclerosis and psoriatic arthritis: A case report. Reumatismo 53, 232\u2013234 (2001).","journal-title":"Reumatismo"},{"key":"1448_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/983902","volume":"2013","author":"N Skroza","year":"2013","unstructured":"Skroza, N. et al. Correlations between psoriasis and inflammatory bowel diseases. Biomed. Res. Int. 2013, 983902 (2013).","journal-title":"Biomed. Res. Int."},{"key":"1448_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","volume":"52","author":"R Poupon","year":"2010","unstructured":"Poupon, R. Primary biliary cirrhosis: A 2010 update. J. Hepatol. 52, 745\u2013758 (2010).","journal-title":"J. Hepatol."},{"key":"1448_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.5021\/ad.2015.27.3.347","volume":"27","author":"EJ Kim","year":"2015","unstructured":"Kim, E. J., Park, H. S., Yoon, H.-S. & Cho, S. A case of psoriasis accompanied by systemic lupus erythematosus. Ann. Dermatol. 27, 347\u2013348 (2015).","journal-title":"Ann. Dermatol."},{"key":"1448_CR22","doi-asserted-by":"publisher","first-page":"key075-226","DOI":"10.1093\/rheumatology\/key075.226","volume":"57","author":"L Sammut","year":"2018","unstructured":"Sammut, L., Litwic, A., Smith, R. & Bartram, S. 002 Biopsy proven giant cell arteritis in a patient with psoriatic arthritis on TNF-alpha inhibitor treated with high dose prednisolone and a switch to secukinumab (anti IL-17). Rheumatology 57, key075-226 (2018).","journal-title":"Rheumatology"},{"key":"1448_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mayocpiqo.2018.07.006","volume":"2","author":"H Kawamoto","year":"2018","unstructured":"Kawamoto, H. et al. Interstitial pneumonia in psoriasis. Mayo Clin. Proc. Innov. Qual. Outcomes 2, 370\u2013377 (2018).","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"1448_CR24","doi-asserted-by":"publisher","first-page":"5919304","DOI":"10.1155\/2019\/5919304","volume":"2019","author":"G Ishikawa","year":"2019","unstructured":"Ishikawa, G. et al. Concomitant interstitial lung disease with psoriasis. Can. Respir. J. 2019, 5919304 (2019).","journal-title":"Can. Respir. J."},{"key":"1448_CR25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11255-018-1868-z","volume":"50","author":"P Ungprasert","year":"2018","unstructured":"Ungprasert, P. & Raksasuk, S. Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: A systematic review and meta-analysis. Int. Urol. Nephrol. 50, 1277\u20131283 (2018).","journal-title":"Int. Urol. Nephrol."},{"key":"1448_CR26","doi-asserted-by":"publisher","first-page":"993733","DOI":"10.3389\/fpubh.2022.993733","volume":"10","author":"H Xie","year":"2022","unstructured":"Xie, H. et al. Characteristics of Graves\u2019 disease in children and adolescents in Nanjing: A retrospective investigation study. Front. Public Health 10, 993733 (2022).","journal-title":"Front. Public Health"},{"key":"1448_CR27","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.2147\/DMSO.S273147","volume":"13","author":"R Abramczyk","year":"2020","unstructured":"Abramczyk, R., Queller, J. N., Rachfal, A. W. & Schwartz, S. S. Diabetes and psoriasis: Different sides of the same prism. Diabetes Metab. Syndr. Obes. 13, 3571\u20133577 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"1448_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000449038","volume":"44","author":"N Aboud","year":"2016","unstructured":"Aboud, N., Depr\u00e9, F. & Salama, A. Is autoimmune thrombocytopenia itself the primary disease in the presence of second diseases data from a long-term observation. Transfus. Med. Hemotherapy 44, 23\u201328 (2016).","journal-title":"Transfus. Med. Hemotherapy"},{"key":"1448_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie, R. A. Comorbidity in multiple sclerosis: Implications for patient care. Nat. Rev. Neurol. 13, 375\u2013382 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"1448_CR30","doi-asserted-by":"publisher","DOI":"10.12890\/2019_001111","author":"MMA Sereshki","year":"2019","unstructured":"Sereshki, M. M. A., Almasi, S., Behnam, B. & Semnani, F. Autoimmune haemolytic anaemia and multiple autoimmune syndrome. Eur. J. Case Rep. Internal Med. https:\/\/doi.org\/10.12890\/2019_001111 (2019).","journal-title":"Eur. J. Case Rep. Internal Med."},{"key":"1448_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5001\/omj.2014.31","volume":"29","author":"S Masood","year":"2014","unstructured":"Masood, S., Sajid, S., Jafferani, A., Tabassum, S. & Ansar, S. Multiple autoimmune syndromes associated with psoriasis: A rare clinical presentation. Oman Med. J. 29, 130\u2013131 (2014).","journal-title":"Oman Med. J."},{"key":"1448_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11926-015-0540-1","volume":"17","author":"A Ogdie","year":"2015","unstructured":"Ogdie, A. & Gelfand, J. M. Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: A review of available evidence. Curr. Rheumatol. Rep. 17, 64 (2015).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1448_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000062","volume":"2","author":"EJ Armstrong","year":"2013","unstructured":"Armstrong, E. J., Harskamp, C. T. & Armstrong, A. W. Psoriasis and major adverse cardiovascular events: A systematic review and meta-analysis of observational studies. J. Am. Heart Assoc. 2, e000062 (2013).","journal-title":"J. Am. Heart Assoc."},{"key":"1448_CR34","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","volume":"167","author":"AR Setty","year":"2007","unstructured":"Setty, A. R., Curhan, G. & Choi, H. K. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses\u2019 Health Study II. Arch. Intern. Med. 167, 1670\u20131675 (2007).","journal-title":"Arch. Intern. Med."},{"key":"1448_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cei.12153","volume":"174","author":"SL Sigurdardottir","year":"2013","unstructured":"Sigurdardottir, S. L., Thorleifsdottir, R. H., Valdimarsson, H. & Johnston, A. The association of sore throat and psoriasis might be explained by histologically distinctive tonsils and increased expression of skin-homing molecules by tonsil T cells. Clin. Exp. Immunol. 174, 139\u2013151 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"1448_CR36","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/jid.2013.508","volume":"134","author":"EA Dowlatshahi","year":"2014","unstructured":"Dowlatshahi, E. A., Wakkee, M., Arends, L. R. & Nijsten, T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: A systematic review and meta-analysis. J. Invest. Dermatol. 134, 1542\u20131551 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"1448_CR37","first-page":"e9708","volume":"12","author":"FM Sahi","year":"2020","unstructured":"Sahi, F. M., Masood, A., Danawar, N. A., Mekaiel, A. & Malik, B. H. Association between psoriasis and depression: A traditional review. Cureus 12, e9708 (2020).","journal-title":"Cureus"},{"key":"1448_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.genhosppsych.2022.01.006","volume":"75","author":"TL Hedemann","year":"2022","unstructured":"Hedemann, T. L., Liu, X., Kang, C. N. & Husain, M. I. Associations between psoriasis and mental illness: An update for clinicians. Gen. Hosp. Psychiatry 75, 30\u201337 (2022).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"1448_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002503","volume":"8","author":"F Cheng","year":"2012","unstructured":"Cheng, F. et al. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. 8, e1002503 (2012).","journal-title":"PLoS Comput. Biol."},{"key":"1448_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jpha.2017.07.006","volume":"8","author":"S Vijayakumar","year":"2018","unstructured":"Vijayakumar, S., Manogar, P., Prabhu, S. & Sanjeevkumar Singh, R. A. Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer\u2019s disease. J. Pharmaceutical Anal. 8, 413\u2013420 (2018).","journal-title":"J. Pharmaceutical Anal."},{"key":"1448_CR41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bioorg.2019.02.044","volume":"87","author":"P Modi","year":"2019","unstructured":"Modi, P., Patel, S. & Chhabria, M. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents. Bioorg. Chem. 87, 240\u2013251 (2019).","journal-title":"Bioorg. Chem."},{"key":"1448_CR42","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11030-012-9387-9","volume":"16","author":"H Pradeep","year":"2012","unstructured":"Pradeep, H. & Rajanikant, G. K. A rational approach to selective pharmacophore designing: An innovative strategy for specific recognition of Gsk3\u03b2. Mol. Divers 16, 553\u2013562 (2012).","journal-title":"Mol. Divers"},{"key":"1448_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/protein\/12.6.439","volume":"12","author":"S Sugio","year":"1999","unstructured":"Sugio, S., Kashima, A., Mochizuki, S., Noda, M. & Kobayashi, K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 12, 439\u2013446 (1999).","journal-title":"Protein Eng."},{"key":"1448_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221\u2013234 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"1448_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.sjbs.2020.10.023","volume":"28","author":"JJ Sahayarayan","year":"2021","unstructured":"Sahayarayan, J. J. et al. In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches. Saudi J. Biol. Sci. 28, 400\u2013407 (2021).","journal-title":"Saudi J. Biol. Sci."},{"key":"1448_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036612","volume":"7","author":"AOM Patschull","year":"2012","unstructured":"Patschull, A. O. M., Gooptu, B., Ashford, P., Daviter, T. & Nobeli, I. In silico assessment of potential druggable pockets on the surface of \u03b11-antitrypsin conformers. PLoS ONE 7, e36612 (2012).","journal-title":"PLoS ONE"},{"key":"1448_CR47","first-page":"78","volume":"13","author":"A Kawai","year":"2018","unstructured":"Kawai, A., Yamasaki, K., Enokida, T., Miyamoto, S. & Otagiri, M. Crystal structure analysis of human serum albumin complexed with sodium 4-phenylbutyrate. Biochem. Biophys. Rep. 13, 78\u201382 (2018).","journal-title":"Biochem. Biophys. Rep."},{"key":"1448_CR48","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"1448_CR49","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J. Med. Chem. 49, 6177\u20136196 (2006).","journal-title":"J. Med. Chem."},{"key":"1448_CR50","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/jm060522a","volume":"49","author":"PD Lyne","year":"2006","unstructured":"Lyne, P. D., Lamb, M. L. & Saeh, J. C. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J. Med. Chem. 49, 4805\u20134808 (2006).","journal-title":"J. Med. Chem."},{"key":"1448_CR51","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1021\/ci4002475","volume":"53","author":"M Ylilauri","year":"2013","unstructured":"Ylilauri, M. & Pentik\u00e4inen, O. T. MMGBSA as a tool to understand the binding affinities of filamin-peptide interactions. J. Chem. Inf. Model 53, 2626\u20132633 (2013).","journal-title":"J. Chem. Inf. Model"},{"key":"1448_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"1448_CR53","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"1448_CR54","doi-asserted-by":"publisher","unstructured":"Venables, W. N. & Ripley, B. D. Modern Applied Statistics with S. (Springer, New York, NY, 2002). https:\/\/doi.org\/10.1007\/978-0-387-21706-2.","DOI":"10.1007\/978-0-387-21706-2"},{"key":"1448_CR55","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"1448_CR56","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1021\/bi700215x","volume":"46","author":"JK Lassila","year":"2007","unstructured":"Lassila, J. K., Keeffe, J. R., Kast, P. & Mayo, S. L. Exhaustive mutagenesis of six secondary active-site residues in escherichia coli chorismate mutase shows the importance of hydrophobic side chains and a helix N-capping position for stability and catalysis. Biochemistry 46, 6883\u20136891 (2007).","journal-title":"Biochemistry"},{"key":"1448_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cbpb.2011.02.002","volume":"159","author":"M Aldeco","year":"2011","unstructured":"Aldeco, M., Arslan, B. K. & Edmondson, D. E. Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): Comparisons with human MAO A and MAO B. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 159, 78\u201383 (2011).","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"1448_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.aax2517","volume":"369","author":"S Maeda","year":"2020","unstructured":"Maeda, S. et al. Structure and selectivity engineering of the M1 muscarinic receptor toxin complex. Science 369, 161\u2013167 (2020).","journal-title":"Science"},{"key":"1448_CR59","doi-asserted-by":"publisher","first-page":"e21549","DOI":"10.1097\/MD.0000000000021549","volume":"99","author":"P Chen","year":"2020","unstructured":"Chen, P. et al. The efficacy and safety of pioglitazone in psoriasis vulgaris. Medicine (Baltimore) 99, e21549 (2020).","journal-title":"Medicine (Baltimore)"},{"key":"1448_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/1568010043343976","volume":"3","author":"S Kuenzli","year":"2004","unstructured":"Kuenzli, S. & Saurat, J.-H. Peroxisome proliferator-activated receptors as new molecular targets in psoriasis. Curr. Drug Targets Inflamm. Allergy 3, 205\u2013211 (2004).","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"1448_CR61","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fphar.2018.01093","volume":"9","author":"PR Devchand","year":"2018","unstructured":"Devchand, P. R., Liu, T., Altman, R. B., FitzGerald, G. A. & Schadt, E. E. The pioglitazone trek via human PPAR Gamma: From discovery to a medicine at the FDA and beyond. Front. Pharmacol. 9, 1093 (2018).","journal-title":"Front. Pharmacol."},{"key":"1448_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12895-016-0049-y","volume":"16","author":"S Singh","year":"2016","unstructured":"Singh, S. & Bhansali, A. Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort). BMC Dermatol. 16, 12 (2016).","journal-title":"BMC Dermatol."},{"key":"1448_CR63","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archdermatol.2009.5","volume":"145","author":"R Mittal","year":"2009","unstructured":"Mittal, R., Malhotra, S., Pandhi, P., Kaur, I. & Dogra, S. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: A randomized, double-blind, placebo-controlled clinical trial. Arch. Dermatol. 145, 387\u2013393 (2009).","journal-title":"Arch. Dermatol."},{"key":"1448_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02190274","volume":"246","author":"M Berger","year":"1996","unstructured":"Berger, M. & Gastpar, M. Trimipramine: A challenge to current concepts on antidepressives. Eur. Arch. Psychiatry Clin. Neurosci. 246, 235\u2013239 (1996).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"1448_CR65","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1046\/j.1468-3083.2001.00278.x","volume":"15","author":"M Gupta","year":"2001","unstructured":"Gupta, M. & Gupta, A. The use of antidepressant drugs in dermatology. J. Eur. Acad. Dermatol. Venereol. 15, 512\u2013518 (2001).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"1448_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/archderm.1979.04010030021008","volume":"115","author":"JA Savin","year":"1979","unstructured":"Savin, J. A., Paterson, W. D., Adam, K. & Oswald, I. Effects of trimeprazine and trimipramine on nocturnal scratching in patients with atopic eczema. Arch. Dermatol. 115, 313\u2013315 (1979).","journal-title":"Arch. Dermatol."},{"key":"1448_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.abd.2019.12.002","volume":"95","author":"MB Weber","year":"2020","unstructured":"Weber, M. B., Recuero, J. K. & Almeida, C. S. Use of psychiatric drugs in dermatology. An. Bras. Dermatol. 95, 133\u2013143 (2020).","journal-title":"An. Bras. Dermatol."},{"key":"1448_CR68","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/archderm.1987.01660290115028","volume":"123","author":"MA Gupta","year":"1987","unstructured":"Gupta, M. A., Gupta, A. K. & Ellis, C. N. Antidepressant drugs in dermatology: An update. Arch. Dermatol. 123, 647\u2013652 (1987).","journal-title":"Arch. Dermatol."},{"key":"1448_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jdcr.2021.09.004","volume":"17","author":"RN Hamid","year":"2021","unstructured":"Hamid, R. N. & Yang, R. G. Treatment of imipramine-induced hyperpigmentation with quality-switched ruby and picosecond lasers. JAAD Case Rep. 17, 12\u201317 (2021).","journal-title":"JAAD Case Rep."},{"key":"1448_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008098","volume":"16","author":"C Gilvary","year":"2020","unstructured":"Gilvary, C. et al. A machine learning and network framework to discover new indications for small molecules. PLoS Comput. Biol. 16, e1008098 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"1448_CR71","volume":"2019","author":"U Matterne","year":"2019","unstructured":"Matterne, U. et al. Oral H1 antihistamines as \u2018add-on\u2019 therapy to topical treatment for eczema. Cochrane Database Syst. Rev. 2019, CD012167 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1448_CR72","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/cpt.2276","volume":"110","author":"A S\u00f6lle","year":"2021","unstructured":"S\u00f6lle, A. et al. Targeted use of placebo effects decreases experimental itch in atopic dermatitis patients: A randomized controlled trial. Clin. Pharmacol. Ther. 110, 486\u2013497 (2021).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1448_CR73","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000210933","volume":"4","author":"LR Lever","year":"2009","unstructured":"Lever, L. R., Hill, S., Dykes, P. J. & Marks, R. Efficacy of topical dimetindene in experimentally induced pruritus and weal and flare reactions. Skin Pharmacol. 4, 109\u2013112 (2009).","journal-title":"Skin Pharmacol."},{"key":"1448_CR74","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1002\/jcp.29413","volume":"235","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda, S., Pooladanda, V. & Godugu, C. Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation. J. Cell Physiol. 235, 5270\u20135283 (2020).","journal-title":"J. Cell Physiol."},{"key":"1448_CR75","doi-asserted-by":"publisher","first-page":"10033","DOI":"10.3390\/ijms241210033","volume":"24","author":"Y-P Zhan","year":"2023","unstructured":"Zhan, Y.-P. & Chen, B.-S. Drug target identification and drug repurposing in psoriasis through systems biology approach, DNN-based DTI model and genome-wide microarray data. Int. J. Mol. Sci. 24, 10033 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1448_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13205-019-2038-4","volume":"10","author":"H Nanda","year":"2020","unstructured":"Nanda, H., Ponnusamy, N., Odumpatta, R., Jeyakanthan, J. & Mohanapriya, A. Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing. 3 Biotech 10, 43 (2020).","journal-title":"3 Biotech"},{"key":"1448_CR77","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12906-021-03359-2","volume":"21","author":"A Ibezim","year":"2021","unstructured":"Ibezim, A., Onah, E., Dim, E. N. & Ntie-Kang, F. A computational multi-targeting approach for drug repositioning for psoriasis treatment. BMC Complement. Med. Therapies 21, 193 (2021).","journal-title":"BMC Complement. Med. Therapies"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01448-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01448-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:06:07Z","timestamp":1751389567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01448-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01448-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"21211"}}